scholarly journals Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?

2022 ◽  
Vol 27 (1) ◽  
pp. 1
Author(s):  
YuYe Wang ◽  
JiaCheng Lv ◽  
JiNing He ◽  
GeHua Wen ◽  
Xu Wu
Keyword(s):  
Tau Protein ◽  
Cognitive Disorders ◽  
Psychoactive Substance

Cognitive Disorders and Tau-Protein Expression Among Retired Aluminum Smelting Workers

2014 ◽  
Vol 56 (2) ◽  
pp. 155-160 ◽  
Author(s):  
Xiaoting Lu ◽  
Ruifeng Liang ◽  
Zhijian Jia ◽  
Hao Wang ◽  
Baolong Pan ◽  
...  
Keyword(s):  
Protein Expression ◽  
Tau Protein ◽  
Cognitive Disorders ◽  
Aluminum Smelting

scholarly journals Tauopathy and cognitive impairment in experimental diabetes mellitus

2017 ◽  
Vol 20 (3) ◽  
pp. 181-184 ◽  
Author(s):  
Mariia V. Matveeva ◽  
Yulia G. SamoiIova ◽  
Natalia G. Zhukova ◽  
Oksana A. Oleynik ◽  
Maria A. Rotkank
Keyword(s):  
Diabetes Mellitus ◽  
Cognitive Impairment ◽  
Glucose Metabolism ◽  
Tau Protein ◽  
Cognitive Disorders ◽  
Effective Strategies ◽  
Increased Risk ◽  
Glycation End Products ◽  
Stress Formation ◽  
The Relationship

Currently, diabetes mellitus (DM) is the most common metabolic disorder, which is manifested by hyperglycemia and leads to vascular and cognitive impairment. Mechanisms of cognitive dysfunction in patients with DM remain highly unclear, thus complicating the search for effective strategies for the prevention and treatment of dementia. Recently, scientists have discussed the issues regarding the relationship between DM and Alzheimers disease (AD), such as risk factors that trigger the cascade of pathological reactions. Patients with DM show an increased risk of developing AD. Similarly, patients with AD have been shown to have impaired insulin and glucose metabolism. Both these diseases have common nosology, pathology and biochemical basics, including oxidative stress, formation of advanced glycation end products, dysregulation of glucose metabolism and altered insulin signaling pathways. The microtubule-associated tau protein is involved in one of the causative mechanisms underlying the development of AD. We provide an overview of the major domestic and foreign data analyses regarding tau protein and the development of cognitive disorders in experimental DM.

scholarly journals Advances in the Relationship between Tau Protein and Morphine De-pendence in Cognitive Dysfunction

2021 ◽  
Vol 9 (4) ◽  
pp. 96
Author(s):  
Qing Ji ◽  
Xin Li
Keyword(s):  
Oxidative Stress ◽  
Cognitive Dysfunction ◽  
Tau Protein ◽  
Hippocampal Neurons ◽  
System Development ◽  
Cognitive Disorders ◽  
Nervous System Development ◽  
Tau Proteins ◽  
Morphine Dependence ◽  
The Relationship

<span lang="EN-US">Morphine is an opioid drug. Long-term use can cause morphine dependence or addiction, and there are cognitive dysfunction such as abnormal mental behavior, decline in learning and memory, and decline in executive ability. The occurrence of this disease is related to many factors, such as oxidative stress, hippocampal neuronal injury, mitochondrial function injury, etc. Tau protein is a microtubule-associated protein involved in nervous system development. Studies have found that hyperphosphorylation of tau proteins can cause apoptosis of hippocampal neurons<sup>[1]</sup>, and tau proteins can cause oxidative stress<sup>[2]</sup>. Therefore, tau proteins play an important role in the pathogenesis of cognitive disorders. The relationship between morphine dependence and cognitive dysfunction is now reviewed.</span>

Transcranial Electrical Stimulation in Post-Stroke Cognitive Rehabilitation

2016 ◽  
Vol 21 (1) ◽  
pp. 55-64 ◽  
Author(s):  
Silvia Convento ◽  
Cristina Russo ◽  
Luca Zigiotto ◽  
Nadia Bolognini
Keyword(s):  
Electrical Stimulation ◽  
Cognitive Rehabilitation ◽  
Cognitive Disorders ◽  
Spatial Neglect ◽  
Transcranial Electrical Stimulation ◽  
Clinical Settings ◽  
Post Stroke ◽  
Neuropsychological Disorders ◽  
Current State ◽  
Stimulation Technique

Abstract. Cognitive rehabilitation is an important area of neurological rehabilitation, which aims at the treatment of cognitive disorders due to acquired brain damage of different etiology, including stroke. Although the importance of cognitive rehabilitation for stroke survivors is well recognized, available cognitive treatments for neuropsychological disorders, such as spatial neglect, hemianopia, apraxia, and working memory, are overall still unsatisfactory. The growing body of evidence supporting the potential of the transcranial Electrical Stimulation (tES) as tool for interacting with neuroplasticity in the human brain, in turn for enhancing perceptual and cognitive functions, has obvious implications for the translation of this noninvasive brain stimulation technique into clinical settings, in particular for the development of tES as adjuvant tool for cognitive rehabilitation. The present review aims at presenting the current state of art concerning the use of tES for the improvement of post-stroke visual and cognitive deficits (except for aphasia and memory disorders), showing the therapeutic promises of this technique and offering some suggestions for the design of future clinical trials. Although this line of research is still in infancy, as compared to the progresses made in the last years in other neurorehabilitation domains, current findings appear very encouraging, supporting the development of tES for the treatment of post-stroke cognitive impairments.

The World’s Favorite Psychoactive SubstanceThe World’s Favorite Psychoactive Substance

PsycCRITIQUES ◽  
2015 ◽  
Vol 6060 (1111) ◽  
Author(s):  
Paula Lundberg-Love ◽  
Cecily Luft
Keyword(s):  
Psychoactive Substance
Sign in / Sign up

Export Citation Format

Share Document